OKYO Pharma News

H.C. Wainwright Maintains OKYO Pharma(OKYO.US) With Buy Rating, Maintains Target Price $7

Futu NewsOct 24 18:31

H.C. Wainwright Maintains OKYO Pharma(OKYO.US) With Buy Rating, Maintains Target Price $7

Futu NewsOct 16 21:31

OKYO Pharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow JonesAug 28 00:49

OKYO Pharma Analyst Ratings

BenzingaAug 28 00:39

HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

BenzingaAug 28 00:39

H.C. Wainwright Maintains OKYO Pharma(OKYO.US) With Buy Rating, Maintains Target Price $7

Futu NewsAug 28 00:32

Buy Rating on OKYO Pharma: U.S. Patent and Strong Trial Results for OK-101 Boosts Market Potential

TipRanksAug 27 23:59

HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

BenzingaJul 12 18:32

Buy Rating Affirmed for OKYO Pharma on Promising Clinical Results of OK-101 for Neuropathic Corneal Pain

TipRanksJul 12 18:19

OKYO Pharma Analyst Ratings

BenzingaJul 11 18:10

HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

BenzingaJul 11 18:10

H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating

MT NewswiresMar 22 23:18

OKYO Pharma Analyst Ratings

BenzingaMar 22 23:05

Analysts Offer Insights on Healthcare Companies: Apyx Medical (APYX) and OKYO Pharma Limited Sponsored ADR (OKYO)

TipRanksMar 22 21:05

Buy Rating Affirmed for OKYO Pharma Amid OK-101's Promising Phase 2 Results and Increased Approval Probability

TipRanksJan 8 21:25

HC Wainwright & Co. Maintains Buy on OKYO Pharma, Raises Price Target to $5

BenzingaJan 8 21:17

OKYO Pharma Analyst Ratings

BenzingaJan 8 21:17

HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $4 Price Target

BenzingaDec 5, 2023 19:49

OKYO Pharma Analyst Ratings

BenzingaDec 5, 2023 19:45

HC Wainwright & Co. Initiates Coverage On OKYO Pharma With Buy Rating, Announces Price Target of $4

BenzingaNov 2, 2023 19:07